Stroke Research Today is a free monthly online journal that collates and summarizes the latest research about Stroke, including details on treatment, recovery, rehabilitation, signs, symptoms.

Volume 5 (2008), Issue 1 (January)

1. Construction of efficacious gait and upper limb functional interventions based on brain plasticity evidence and model-based measures for stroke patients.
   ScientificWorldJournal, 7: 2031-45. [Abstract] [Full-text]
2. Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial.
   Eur J Neurol, 15(1): 82-90. [Abstract] [Full-text]
3. Leukaemia inhibitory factor is over-expressed by ischaemic brain tissue concomitant with reduced plasma expression following acute stroke.
   Eur J Neurol, 15(1): 29-37. [Abstract] [Full-text]
4. Early treatment after a symptomatic event is not associated with an increased risk of stroke in patients undergoing carotid stenting.
   Eur J Neurol, 15(1): 2-5. [Abstract] [Full-text]
5. High prevalence of inherited thrombophilia in 'presumed peri-neonatal' ischemic stroke.
   Eur J Haematol, 80(1): 71-5. [Abstract] [Full-text]
6. Antiplatelet agents for stroke prevention following transient ischemic attack.
   South Med J, 101(1): 70-8. [Abstract] [Full-text]
7. Subthreshold depression and cognitive impairment but not demented in stroke patients during their rehabilitation.
   Acta Neurol Scand, 117(2): 133-40. [Abstract] [Full-text]
8. Associations between meteorological variables and acute stroke hospital admissions in the west of Scotland.
   Acta Neurol Scand, 117(2): 85-9. [Abstract] [Full-text]
9. Statin therapy in stroke prevention: a meta-analysis involving 121,000 patients.
   Am J Med, 121(1): 24-33. [Abstract] [Full-text]
10. Rural Organisation of Acute Stroke Teams project.
    Intern Med J, 38(1): 32-7. [Abstract] [Full-text]
11. Endarterectomy or carotid artery stenting: the quest continues.
    Am J Surg, 195(2): 259-69. [Abstract] [Full-text]
12. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    Pediatr Blood Cancer, 50(3): 599-602. [Abstract] [Full-text]
13. Emotional facial palsy following striato-capsular infarction.
    J Neurol Neurosurg Psychiatry, 79(2): 193-4. [Abstract] [Full-text]
14. Chlamydia pneumoniae seropositivity in aetiological subtypes of brain infarction and carotid atherosclerosis: a case control study.
    J Neurol Neurosurg Psychiatry, 79(2): 147-51. [Abstract] [Full-text]
15. Cognitive complaints in the early phase after stroke are not indicative of cognitive impairment.
    J Neurol Neurosurg Psychiatry, 79(2): 143-6. [Abstract] [Full-text]
16. Risk of vertebrobasilar stroke and chiropractic care: results of a population-based case-control and case-crossover study.
    Spine, 33(4): S176-83. [Abstract] [Full-text]
17. Examining vertebrobasilar artery stroke in two Canadian provinces.
    Spine, 33(4): S170-5. [Abstract] [Full-text]
18. Fatal neonatal stroke from a prenatal cardiac thrombus.
    Pediatr Neurol, 38(2): 140-2. [Abstract] [Full-text]
19. Ischemic stroke and excellent recovery after administration of intravenous tissue plasminogen activator.
    Pediatr Neurol, 38(2): 126-9. [Abstract] [Full-text]
20. Neuropsychologic outcomes in a case series of twins discordant for perinatal stroke.
    Pediatr Neurol, 38(2): 118-25. [Abstract] [Full-text]
21. Neural stem cells reduce brain injury after unilateral carotid ligation.
    Pediatr Neurol, 38(2): 86-92. [Abstract] [Full-text]
22. Transcranial Doppler scanning and the assessment of stroke risk in children with haemoglobin sickle cell disease.
    Arch Dis Child, 93(2): 138-41. [Abstract] [Full-text]
23. Tissue-type plasminogen activator as a therapeutic target in stroke.
    Expert Opin Ther Targets, 12(2): 159-70. [Abstract] [Full-text]
24. Altered soluble epoxide hydrolase gene expression and function and vascular disease risk in the stroke-prone spontaneously hypertensive rat.
    Hypertension, 51(2): 567-73. [Abstract] [Full-text]
25. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial.
    Arterioscler Thromb Vasc Biol, 28(2): 341-7. [Abstract] [Full-text]
26. Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats.
    J Pharmacol Exp Ther, 324(2): 834-49. [Abstract] [Full-text]
27. Profile and associations of central pulse wave velocity and central pulse pressure among ischemic stroke patients.
    Eur J Neurol, 15(2): 196-8. [Abstract] [Full-text]
28. Nursing neurologic assessments after cardiac operations.
    Ann Thorac Surg, 85(2): 554-60. [Abstract] [Full-text]
29. The influence of epiaortic ultrasonography on intraoperative surgical management in 6051 cardiac surgical patients.
    Ann Thorac Surg, 85(2): 548-53. [Abstract] [Full-text]
30. Does intensive management of cerebral hemodynamics and atheromatous aorta reduce stroke after coronary artery surgery?
    Ann Thorac Surg, 85(2): 513-9. [Abstract] [Full-text]
31. Functional MRI of delayed chronic lithium treatment in rat focal cerebral ischemia.
    Stroke, 39(2): 439-47. [Abstract] [Full-text]
32. Preferred involvement of the basal ganglia after lenticulostriate infarction as a possible indicator of different gray and white matter vulnerability.
    Stroke, 39(2): 494-6. [Abstract] [Full-text]
33. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease.
    Stroke, 39(2): 497-502. [Abstract] [Full-text]
34. A very early rehabilitation trial for stroke (AVERT): phase II safety and feasibility.
    Stroke, 39(2): 390-6. [Abstract] [Full-text]
35. Serial electrocardiographic assessments significantly improve detection of atrial fibrillation 2.6-fold in patients with acute stroke.
    Stroke, 39(2): 480-2. [Abstract] [Full-text]
36. Effects of magnesium treatment in a model of internal capsule lesion in spontaneously hypertensive rats.
    Stroke, 39(2): 448-54. [Abstract] [Full-text]
37. Posturography in patients with stroke: estimating the percentage of body weight on each foot from a single force platform.
    Stroke, 39(2): 489. [Abstract] [Full-text]
38. A systematic review of outcomes in patients with staged carotid artery stenting and coronary artery bypass graft surgery.
    Stroke, 39(2): 361-5. [Abstract] [Full-text]
39. Temporal thresholds for infarction and hypothermic protection in Long-Evans rats: factors affecting apparent 'reperfusion injury' after transient focal ischemia.
    Stroke, 39(2): 421-6. [Abstract] [Full-text]
40. No association of PLIN polymorphisms with hemorrhagic and ischemic stroke.
    Stroke, 39(2): 470-2. [Abstract] [Full-text]
41. Identification of variations in blood-brain barrier opening after cerebral ischemia by dual contrast-enhanced magnetic resonance imaging and T 1sat measurements.
    Stroke, 39(2): 427-32. [Abstract] [Full-text]
42. Nortriptyline protects mitochondria and reduces cerebral ischemia/hypoxia injury.
    Stroke, 39(2): 455-62. [Abstract] [Full-text]
43. Middle cerebral artery infarcts encompassing the insula are more prone to growth.
    Stroke, 39(2): 373-8. [Abstract] [Full-text]
44. Cognitive outcome at early school age in term-born children with perinatally acquired middle cerebral artery territory infarction.
    Stroke, 39(2): 403-10. [Abstract] [Full-text]
45. Early neutrophilia is associated with volume of ischemic tissue in acute stroke.
    Stroke, 39(2): 355-60. [Abstract] [Full-text]
46. Intravenous rosuvastatin for acute stroke treatment: an animal study.
    Stroke, 39(2): 433-8. [Abstract] [Full-text]
47. Stroke awareness in Brazil: alarming results in a community-based study.
    Stroke, 39(2): 292-6. [Abstract] [Full-text]
48. Predicting stroke risk in hypertensive patients with coronary artery disease: a report from the INVEST.
    Stroke, 39(2): 343-8. [Abstract] [Full-text]
49. Diffusion-weighted imaging in stroke attributable to internal carotid artery dissection: the significance of vessel patency.
    Stroke, 39(2): 483-5. [Abstract] [Full-text]
50. Subcortical lacunes are associated with executive dysfunction in cognitively normal elderly.
    Stroke, 39(2): 397-402. [Abstract] [Full-text]
51. Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial.
    Stroke, 39(2): 366-72. [Abstract] [Full-text]
52. Comparison of intraarterial and intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign.
    Stroke, 39(2): 379-83. [Abstract] [Full-text]
53. Treatment of hyperglycemia in ischemic stroke (THIS): a randomized pilot trial.
    Stroke, 39(2): 384-9. [Abstract] [Full-text]
54. Association of adiponectin with cerebrovascular disease: a nested case-control study.
    Stroke, 39(2): 323-8. [Abstract] [Full-text]
55. Medical complications in a comprehensive stroke unit and an early supported discharge service.
    Stroke, 39(2): 414-20. [Abstract] [Full-text]
56. Factors associated with the decision to hospitalize patients after transient ischemic attack before publication of prediction rules.
    Stroke, 39(2): 411-3. [Abstract] [Full-text]
57. Proprioception of the shoulder after stroke.
    Arch Phys Med Rehabil, 89(2): 333-8. [Abstract] [Full-text]
58. Reliability of mental chronometry for assessing motor imagery ability after stroke.
    Arch Phys Med Rehabil, 89(2): 311-9. [Abstract] [Full-text]
59. Gait asymmetry in community-ambulating stroke survivors.
    Arch Phys Med Rehabil, 89(2): 304-10. [Abstract] [Full-text]
60. ABILOCO: a Rasch-built 13-item questionnaire to assess locomotion ability in stroke patients.
    Arch Phys Med Rehabil, 89(2): 284-90. [Abstract] [Full-text]
61. Early prediction of functional recovery after experimental stroke: functional magnetic resonance imaging, electrophysiology, and behavioral testing in rats.
    J Neurosci, 28(5): 1022-9. [Abstract] [Full-text]

© 2004-2010 Stroke Research Today. All Rights Reserved.